课题基金 / 基金详情

Basic Research for AIDS control A01 ; Host factors necessary for HIV-1 replication

Basic Research for AIDS control A01 ; Host factors necessary for HIV-1 replication
艾滋病控制基础研究A01;
批准号:
10180101
负责人:
KOYANAGI Yoshio
金额:
$118.46万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research on Priority Areas (A)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 2001

项目摘要

项目成果

KOYANAGI Yoshio的其他基金

相似基金

相关文献

中文摘要
翻译
Koyanagi等利用SCID-PBL小鼠系统报道,TRAIL而非FasL参与了感染个体中CD 4(+)T细胞的凋亡性死亡。此外,他们还发现TRAIL也参与了HIV中枢神经系统感染小鼠模型中的神经元细胞死亡。Shioda在亚洲人群中发现了CCR 5基因的缺失突变,并表明该突变影响了CCR 5的表面运输,导致受影响个体对HIV-1感染的敏感性降低。冈本确定了病毒转录所必需的宿主因子。一种是AES/TLE,作为NF-κ B p65的共阻遏物。另一种是FUS/TLS,作为NF-κ B的共激活剂。增田在HIV-1整合酶中发现了一种新的核输入信号。Shida报道CRAM 1对于Rev蛋白的寡聚化是必需的,并且人CRAM 1甚至在鼠细胞中也起作用。
英文摘要
Koyanagi reported that TRAIL but not FasL was involved in the apoptotic death of CD4(+) T cells in infected individuals using SCID-PBL mouse system. Furthermore, they showed that TRAIL was also involved in the neuronal cell death in a murine model of HIV central nervous system infection. Shioda identified a deletion mutation in the CCR5 gene specifically seen in Asian population and showed that this mutation affected the surface trafficking of CCR5, resulting in the low sensitivity to HIV-1 infection in the affected individuals. Okamoto identified the host factors essential for viral transcription. One was AES/TLE, as a co-repressor of NF-kappaB p65. Another was FUS/TLS, as a co-activator of NF-kappaB. Masuda found a novel nuclear import signal located in HIV-1 integrase. Shida reported that CRAM1 is necessary for the oligomerization of Rev protein and that human CRAM1 also functioned even in murine cells.
期刊论文(63)
专著(0)
科研奖励(0)
会议论文
Ichiyama K.: "A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity"Proc.Natl.Acad.Sci. USA. 100(7). 4185-4190 (2003)
Ichiyama K.:“一种十二指肠可吸收的 CXC 趋化因子受体 4 拮抗剂 KRH-1636,表现出有效且选择性的抗 HIV-1 活性”Proc.Natl.Acad.Sci。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Uranishi H. et al: "Involvement of the pro-oncoprotein TLS (Translocated in liposarcoma) in nuclear factor - kB p65-mediated transcription as a coactivator"J. Biol. Chem.. 276. 13395-13401 (2001)
Uranishi H. 等人:“原癌蛋白 TLS(在脂肪肉瘤中易位)参与核因子 - kB p65 介导的转录作为共激活剂”J.
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Sakuragi J, Iwamoto A, Shioda T: "Dissociation of genomic dimerization from packaging functions and virion maturation of human immunodeficiecny virus type 1"Journal of Virology. 76. 959-967 (2002)
Sakuragi J、Iwamoto A、Shioda T:“基因组二聚化与 1 型人类免疫缺陷病毒的包装功能和病毒颗粒成熟的分离”病毒学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hoshino Y, Nakata K, Hoshino S, Honda Y, Tse D, Shioda T, Rom W, Weiden M: "Maximal HIV-1 replication in alveolar macrophages during tuberculosis requires both lymphocyte contact and cytokines"Journal of Experimental. Medicine. (印刷中).
Hoshino Y、Nakata K、Hoshino S、Honda Y、Tse D、Shioda T、Rom W、Weiden M:“结核病期间肺泡巨噬细胞中的最大 HIV-1 复制需要淋巴细胞接触和细胞因子”《实验医学杂志》(印刷版)。期间)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 62 条
    Analysis of viral infection and innate immune response using humanized mice
    • 批准号:
      24390112
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.98万
    • 财政年份:
      2012
    • 负责人:
      KOYANAGI Yoshio
    • 依托单位:
    Study of novel HIV restriction factors
    • 批准号:
      23659229
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2011
    • 负责人:
      KOYANAGI Yoshio
    • 依托单位:
    Functional analysis of cellular membrane proteins for generation of viral envelope and transmission
    • 批准号:
      21390137
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.06万
    • 财政年份:
      2009
    • 负责人:
      KOYANAGI Yoshio
    • 依托单位:
    Investigation of tissue destruction signals on viral encephalitis
    • 批准号:
      16390112
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.6万
    • 财政年份:
      2004
    • 负责人:
      KOYANAGI Yoshio
    • 依托单位:
    国内基金
    海外基金
    基于病人旅程地图的HIV/AIDS患者双轨调适策略的混合性研究
    基于潜变量增长混合模型的HIV/AIDS患者症状负担发展轨迹研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      胡亚丽
    • 依托单位:
    基于RET理论模型下的曼陀罗彩绘疗法在老年HIV/AIDS患者中的心理干预研究
    IL-33/NF-κB通路在臭氧暴露致HIV/AIDS患者免疫损伤中的调控机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
    • 依托单位: